Floatz logo

MOTEXAFIN GADOLINIUM HYDRATE

Liver Cancer

American College of Radiology Imaging NetworkSmall moleculeN/ADormant
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

112 Active assets in the Liver Cancer cohort.

Asset / SponsorPhaseRating
Bxcl501
Uppsala University Hospital
Phase 4BBB
Inno-206
Shanghai Zhongshan Hospital
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB
S-Ketamine
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Tranexamic Acid
Konkuk University Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

MOTEXAFIN GADOLINIUM HYDRATE is also rated in:

brain neoplasmDormant
BB
Indicative ·
67 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
central nervous system neoplasmDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →